Search results
Red carpet with a cause: This fashion show fundraiser helps kids with cancer
The Record· 4 days agoIt is now a life purpose for Paula Corrieri, of Wayne, whose 15-year-old son, Rocco Sivolella, died...
Apollomics shares target cut on Phase 3 study results By Investing.com
Investing.com· 5 days agoThe adjustment came in response to recently revealed Phase 3 study results which did not meet the...
Opinion | Ending Oncology's Toxic Relationship With High Chemotherapy Doses
MedPage Today· 3 days agoMany years ago, my patient, a woman in her fifties with chronic myeloid leukemia (CML), got her...
ExxonMobil Hit with $725M Verdict for Failure to Warn About Cancer-Causing Benzene in Gasoline
Morningstar· 3 days agoA Philadelphia jury has returned a $725.5 million verdict against ExxonMobil, finding the company's failure to warn about known health risks of exposure to cancer-causing benzene in its petroleum ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 6 days agoFirst-in-class IV SMARCA2 degrader, PRT3789 and potentially best-in-class CDK9 inhibitor, PRT2527 remain on track to generate initial proof-of-concept data in 2024 New preclinical data presented at AACR 2024 included first characterization of
Benjamin F. Edwards & Company Inc. Buys Shares of 542 BeiGene, Ltd. (NASDAQ:BGNE)
ETF DAILY NEWS· 10 hours agoBenjamin F. Edwards & Company Inc. purchased a new stake in shares of BeiGene, Ltd. (NASDAQ:BGNE – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities ...
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 5 days agoRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q1 2024 Earnings Call Transcript May 7, 2024 Rigel...
Dow Surges Over 100 Points; EyePoint Pharmaceuticals Shares Plunge - Spirit Airlines (NYSE:SAVE)
Benzinga· 7 days agoShares of GlycoMimetics, Inc GLYC were down 82% to $0.3330 after the company announced topline...
AML/T cell interactomics uncover correlates of patient outcomes and the key role of ICAM1 in T cell...
Nature· 4 days agoT cells are important for the control of acute myeloid leukemia (AML), a common and often deadly malignancy. We observed that some AML ...
Rigel Reports First Quarter 2024 Financial Results and Provides Business Update
Yucaipa News Mirror· 6 days agoFirst quarter 2024 total revenue of $29.5 million, which includes TAVALISSE® net product sales of $21.1 million and REZLIDHIA® net product sales of $4.9 millionExpanded Rigel's portfolio with acquisition of
